Na-lactate
Drugintravenous
Other names: Sodium lactate
NCT Number: NCT04710875
Lactate may have anti-lipolytic effects when plasma concentrations of lactate reach levels similar to those seen during high intensity exercise.
This study aims to investigate how lactate concentrations similar to those achieved during high intensity exercise affects lipolysis in humans. In addition to this, to investigate how increased lactate concentrations affects glucose- and amino acid metabolism.
8 healthy males will be included. Study participants will undergo two separate investigation days that will be identical except for the interventions:
1. Intravenous sodium D/L-lactate 2. Intravenous sodium chloride.
The study consists of a 3-hour basal period followed by a 3-hour hyperinsulinemic euglycemic clamp. During the study we will:
* Estimate insulin sensitivity during the hyperinsulinemic euglycemic clamp (M value) * Use tracer kinetics to estimate lipid-, glucose and amino acid metabolism using [9,10-3H]-palmitate, [3-3H]-glucose, [15N]-phenylalanine, [15N]-tyrosine, [2H4]-tyrosine and [13C]-Urea. * Do muscle- and adipose tissue biopsies for analyses of signaling pathways involved in regulation of lipid-, glucose and amino acid metabolism. * Do blood samples of relevant hormones, metabolites and cytokines. * Use indirect calorimetry to estimate study participants' resting energy expenditure and respiratory quotient during the basal period. * Estimate cardiac ejection fraction by echocardiography and measure blood pressure during both the basal- and clamp period.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Medical/Steno Aarhus research laboratory, Aarhus, Central Region Denmark, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
intravenous
Other names: Sodium lactate
Intravenous
Other names: NaCl
Time frame: 2 hours (1 hour basal period, 1 hour clamp)
Change in [9,10-3H]-palmitate tracer flux
Time frame: 6 hours (3 hours basal period, 3 hours clamp)
Change in glucose metabolism quantified with [3-3H]-glucose tracer
Time frame: 3 hours.
Hyperinsulinaemic euglycaemic clamp with 0.6mU/kg/min insulin and 20% glucose to calculate M value. Difference between interventions.
Time frame: 6 hours
Change in aminoacid metabolism quantified with [15N]-phenylalanine, [15N]tyrosine, [2H4]tyrosine and [13C]-Urea tracers.
Time frame: 20 minutes
Change in estimation of resting energy expenditure during clamp. Difference between interventions.
Time frame: 20 minutes
Change in estimation of respiratory quotient during basal period. Difference between interventions.
Time frame: 15 minutes
Change in cardiac ejection fraction during basal period. Difference between interventions.
Time frame: 15 minutes
Change in cardiac ejection fraction during clamp period. Difference between interventions.
Time frame: 2 x 10 min
blood pressure (systolic and diastolic) during basal- and clamp
Time frame: 6 hours.
Insulin concentrations. Difference between interventions.
Time frame: 6 hours.
c-peptid concentrations. Difference between interventions.
Time frame: 6 hours.
glucagon concentrations. Difference between interventions.
Time frame: 6 hours.
cortisol concentrations. Difference between interventions.
Time frame: 6 hours.
Ghrelin concentrations. Difference between interventions.
Time frame: 6 hours.
GDF-15 concentrations. Difference between interventions.
Time frame: 6 hours.
Free fatte acids concentrations. Difference between interventions.
Time frame: 6 hours.
glucose concentrations. Difference between interventions.
Time frame: 6 hours.
lactate concentrations. Difference between interventions.
Time frame: After 3 and 5 hours of intervention
Western blot examinations of muscle tissue biopsies
Time frame: After 3 and 5 hours of intervention
Western blot examinations of adipose tissue biopsies
University of Aarhus
Other
Acronym: LILACH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04299815
Glucose Metabolism Disorders, Healthy
Aarhus, Denmark
View Trial DetailsNCT05032521
Actue Circulatory Failure, Hyperlactatemia
Dijon, France
View Trial DetailsNCT05505396
Acute Brain Injury, Brain Diseases
Copenhagen, Denmark
View Trial DetailsNCT04046861
Bypass Complication, Cardiac Disease
Maribor, Slovenia
View Trial Details